Description
Elvitegravir is an antiviral compound that inhibits integrase activity. This compound is clinically used to treat HIV infection.
Elvitegravir is an antiviral compound that inhibits integrase activity. This compound is clinically used to treat HIV infection.
Cas No. | 697761-98-1 |
---|---|
Purity | ≥98% |
Formula | C23H23ClFNO5 |
Formula Wt. | 447.88 |
IUPAC Name | 6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid |
Appearance | White to off white powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
Info Sheet | E4785 Info Sheet PDF |
---|---|
Brochures | Antivirals Booklet |
Reviriego C. Elvitegravir for the treatment of HIV infection. Drugs Today (Barc). 2014 Mar;50(3):209-17. PMID: 24696866.
Shimura K, Kodama E, Sakagami Y, et al. Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137). J Virol. 2008 Jan;82(2):764-74. PMID: 17977962.